Portugal, March 6 -- Portugal based Novo Nordisk Portugal, Lda. has secured contract from Unidade Local De Saude De Santo Antonio, E. P. E. for Medications For The Locomotor System, Used In The Treatment Of Endocrine Diseases And Hormones Under Cp 2024/780 Of The Spms, For The Year 2026. The value of the contract is worth 1322172 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....